As MISSD approaches the end of another incredible year, we want to express our heartfelt gratitude for your support that enabled us to achieve remarkable milestones in 2023. We’re excited to continue making a positive difference in the coming year. Our 2024 public health ads will reach Canada, Australia and several new cities across the US. We’ll also be presenting at multiple conferences from DC to Kansas City and points in between.

With the year-end fast approaching, there’s still time to make a tax-deductible donation for 2023. Your support is essential in helping us continue our vital work.

Together, we are increasing awareness of akathisia and related adverse drug effects that can negatively impact mental health and public safety. Once again, thank you for being an integral part of our MISSD family. We can’t wait to embark on another year of progress and change with you by our side.

More than 30 prominent figures in critical psychiatry have published a recent article in the British Medical Journal (BMJ) “calling on the UK government to acknowledge the evidence that antidepressants are no better than placebos for most patients and to increase funding of social and psychological interventions while decreasing drug prescriptions. Following these guidelines can reduce akathisia & related prescribed harm. Read more at https://www.madinamerica.com/2023/12/stop-using-antidepressants-except-for-the-most-severe-depression-experts-say/.

We’re wishing a Happy Hanukkah to all who are celebrating! May your candles burn bright this season.

Fans of the pop singer note her increasing movements, to include fidgeting and rocking back and forth during interviews. The star was forced to take several drugs that are associated with akathisia. Read the full article at https://www.dailymail.co.uk/health/article-12815805/Britneys-fans-akathisia-psychiatric-condition-say-still.html?fbclid=IwAR3VKu4LfWMtNh49btjgn2KgM8ONraXScKxaRhLQdoto99LksJuWyK0pWsI.

Our latest campaign is focused on helping ensure vets and military personnel receive therapeutic mental health care. Listen to K9s for Veterans founder, Michael Tellerino, and Wendy Dolin discuss this collaboration and the need for akathisia awareness on our recent podcast. See the full release at https://www.einpresswire.com/article/671027397/missd-seeks-support-to-combat-akathisia-and-save-lives and take a sneak peek of our upcoming public health video.

Dear Friends of MISSD,

It’s Giving Tuesday–one of the most significant giving days of the year. Can we count on you to make a tax-deductible contribution to help us reduce suffering and save lives?

Your support enables MISSD to increase akathisia awareness, provide free educational resources, and expand our reach. One example is our latest campaign aimed at helping veterans receive therapeutic care. Our recent press release offers a sneak peek of this upcoming video and a new podcast interview with K9s for Veterans founder Michael Tellerino and me. The informative and profoundly moving stories underscore the importance of our mission. See https://www.einpresswire.com/article/667671324/raising-awareness-of-akathisia-and-suicide-risks-among-veterans. 

If you’ve already made your Giving Tuesday gift, thank you. If you haven’t, please take a minute to join us in making a positive difference for others. Your donations are more than just contributions; they are lifelines that empower us to continue our work. 

With gratitude–Wendy Dolin and the MISSD Team

The Texas Attorney General’s office sues Pfizer over ADHD drug, Quillivant–which can cause serious adverse effects to include akathisia, mania & sexual dysfunction.

“I am horrified by the dishonesty we uncovered in this investigation,” said Texas AG Ken Paxton. Pfizer “intentionally concealed and failed to disclose the issues with Quillivant to receive taxpayer-funded benefits through Texas Medicaid, defrauding the state and endangering children.” Read the article at https://www.foxbusiness.com/politics/texas-ag-sues-pfizer-allegedly-selling-medicine-knew-ineffective-manipulated-quality-test-results. Read the adverse effects of Quillivant at https://www.rxlist.com/quillivant-xr-drug.htm#warnings.

We’re pleased to announce our latest awareness campaign focuses on veterans and the military and kicks off today with a new Akathisia Stories episode. The campaign includes targeted military base ads, and a compelling public health video in which veterans share first-hand accounts of akathisia-induced suicidality. Read more at https://www.einpresswire.com/article/667671324/raising-awareness-of-akathisia-and-suicide-risks-among-veterans and listen to the podcast interview with Wendy Dolin and K9s for Veterans founder, Michael Tellerino at https://www.studiocchicago.com/akathisia-stories.

The public is becoming increasingly aware of adverse effects some people suffer long after discontinuing SSRIs. This NY Times article covers PSSD. We’d like to see an article published about withdrawal akathisia next. Read the full article at https://www.nytimes.com/2023/11/09/health/antidepressants-ssri-sexual-dysfunction.html?fbclid=IwAR3XQ3lSo4feRqsRRgQZzYYNOvJxyO_tRn8fVqzdfADuk4UW8Jt395wxga8.

Dr. Dennis Miller, is a retired chain store pharmacist, and author of The Shocking Truth About Pharmacy: A Pharmacist Reveals All the Disturbing Secrets, has written an excellent article listing 25 things the FDA can do to improve patient safety and regain public trust. Read them at https://www.peoplespharmacy.com/articles/25-things-fda-must-do-to-rebuild-its-reputation.